Literature DB >> 24769008

Nicotine, an α7 nAChR agonist, reduces lipopolysaccharide-induced inflammatory responses and protects fetuses in pregnant rats.

Jinying Yang1, Shao-Qing Shi2, Leili Shi3, Dajun Fang1, Huishu Liu4, Robert E Garfield5.   

Abstract

OBJECTIVE: The objective of the study was to examine the effects of nicotine, an α7 nicotinic acetylcholine receptor agonist, on lipopolysaccharide (LPS)-induced inflammatory responses in rats during pregnancy. STUDY
DESIGN: Pregnant Sprague Dawley rats were randomly divided into groups (n = 6 rats/group): group 1 rats each received a single intraperitoneal injection of LPS (25 μg/kg) on gestation day 16; group 2 rats were first pretreated with nicotine (1 mg/kg per day, subcutaneously) on gestation days 14 and 15 and then were treated with single injections of LPS on gestational day 16; group 3 rats were treated with the vehicle (saline) used for groups 2 and 3 (controls). Maternal blood was collected at 6 hours and 24 hours after LPS and vehicle treatments and assayed for tumor necrosis factor (TNF)-α, interleukin-6 (IL-6), and interleukin-10 (IL-10). In addition, the number of live pups and pup weights were obtained at the time of delivery.
RESULTS: LPS treatment significantly (P < .001) elevates maternal blood levels of TNF-α and IL-6 but not IL-10 (P > .05). Nicotine treatment significantly reduces LPS-induced TNF-α and IL-6 concentrations (P < .001) but does not change (P > .05) IL-10 levels. The number of live pups in the LPS group are significantly lower (P < .001) than the vehicle treated controls, and nicotine treatment significantly (P < .011) reverses this change. Similarly, fetal weights are lower following LPS (P < .016) and higher (P < .024) in the group treated with nicotine plus LPS.
CONCLUSION: Nicotine reduces the LPS-induced inflammatory responses and rescues the fetus in rats during pregnancy. Thus, nicotine exerts dramatic antiinflammatory effects. These observations have important implications for control of inflammatory responses during pregnancy.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  cytokines; inflammation; nicotine; parturition; preeclampsia; preterm birth; α7 nicotinic acetylcholine receptor agonist

Mesh:

Substances:

Year:  2014        PMID: 24769008     DOI: 10.1016/j.ajog.2014.04.026

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  6 in total

1.  Effect of nicotine on placental ischemia-induced complement activation and hypertension in the rat.

Authors:  Connor F Laule; Cameron R Wing; Evan J Odean; Jacob A Wilcox; Jeffrey S Gilbert; Jean F Regal
Journal:  J Immunotoxicol       Date:  2017-12       Impact factor: 3.000

2.  Interactive effects of maternal cigarette smoke, heat stress, hypoxia, and lipopolysaccharide on neonatal cardiorespiratory and cytokine responses.

Authors:  Fiona B McDonald; Kumaran Chandrasekharan; Richard J A Wilson; Shabih U Hasan
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-10-12       Impact factor: 3.619

3.  Ropivacaine with intraspinal administration alleviates preeclampsia-induced kidney injury via glycocalyx /alpha 7 nicotinic acetylcholine receptor pathway.

Authors:  Shen Sun; Yaojun Lu; Fubo Tian; Shaoqiang Huang
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

4.  Nicotine protects fetus against LPS-induced fetal growth restriction through ameliorating placental inflammation and vascular development in late pregnancy in rats.

Authors:  Junjie Bao; Yong Zou; Yuanyuan Liu; Li Yuan; Robert E Garfield; Huishu Liu
Journal:  Biosci Rep       Date:  2019-07-02       Impact factor: 3.840

5.  Activation of cholinergic anti-inflammatory pathway involved in therapeutic actions of α-mangostin on lipopolysaccharide-induced acute lung injury in rats.

Authors:  Zhe Yang; Qin Yin; Opeyemi Joshua Olatunji; Yan Li; Shu Pan; Dan-Dan Wang; Jian Zuo
Journal:  Int J Immunopathol Pharmacol       Date:  2020 Jan-Dec       Impact factor: 3.219

Review 6.  Nicotine in Inflammatory Diseases: Anti-Inflammatory and Pro-Inflammatory Effects.

Authors:  Wenji Zhang; Hui Lin; Mingmin Zou; Qinghua Yuan; Zhenrui Huang; Xiaoying Pan; Wenjuan Zhang
Journal:  Front Immunol       Date:  2022-02-18       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.